Pharmacokinetic differences between morning and evening administration of cyclosporine and tacrolimus therapy

Transplantation Proceedings

Volumn 37, Issue 4, 2005, Pages 1739-1740

  Iwahori, T ^a   Takeuchi, H ^a,c   Matsuno, N ^a   Johjima, Y ^a   Konno, O ^a   Nakamura, Y ^a   Hama, K ^a   Uchiyama, M ^a   Ashizawa, T ^a   Okuyama, K ^a   Nagao, T ^a   Abudoshukur, M ^a   Hirano, T ^b   Oka, K ^b  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^c NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ADULT; AREA UNDER THE CURVE; BLOOD SAMPLING; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG MONITORING; FEMALE; HUMAN; MALE; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; AREA UNDER CURVE; CIRCADIAN RHYTHM; CYCLOSPORINE; DRUG ADMINISTRATION SCHEDULE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; TACROLIMUS;

EID: 20344374668     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.02.104     Document Type: Conference Paper

References (6)

1. N. Chateauvert, H. Cote Circadian variations in the pharmacokinetics of a new microemulsion formulation of cyclosporine in cardiac transplant recipients Pharmacotherapy 18 1998 364
2. I. Milanian, A.J. Ghods, M. Mahmoudian Study of circadian variation of cyclosporine pharmacokinetics Transplant Proc 29 1997 2930
3. J.M. Kovarik, E.A. Mueller, J.B. van Bree Within-day consistency in cyclosporine pharmacokinetics from a microemulsion formulation in renal transplant patients Therapeutic Drug Monitoring 16 1994 232
4. D.I. Min, H.-Y. Chen, A. Fabrega Circadian variation of tacrolimus disposition in liver allograft recipients Transplantation 62 1996 1190
5. H. Toda, S. Satoh, M. Iinuma Chronopharmacokinetics of tacrolimus in kidney transplant recipients occurrence of acute rejection J Clinic Pharmacol 43 2003 859
6. B. Lemmer Chronopharmacokinetics implication for drug treatment J Pharmacol 51 1999 887